Back
Hexcel Corp. 10K Form
Buy
56
HXL
Hexcel Corp.
Last Price:
$77.61
Seasonality Move:
5.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-22 | 10Q | HXL/Hexcel Corp. Quarterly |
| 2023-10-23 | 10Q | HXL/Hexcel Corp. Quarterly |
| 2023-07-24 | 10Q | HXL/Hexcel Corp. Quarterly |
| 2023-04-24 | 10Q | HXL/Hexcel Corp. Quarterly |
| 2022-10-24 | 10Q | HXL/Hexcel Corp. Quarterly |
| 2022-07-25 | 10Q | HXL/Hexcel Corp. Quarterly |
Receive HXL News And Ratings
See the #1 stock for the next 7 days that we like better than HXL
HXL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.9B |
|---|---|
| Cash Flow: | $94.9M |
| Price / Cash Flow: | 31.98 |
| Annual Sales: | $19.68 |
| Price / Book: | 3.83 |
Profitability
| EPS (TTM): | 0.84850 |
|---|---|
| Net Income (TTM): | $68.8M |
| Gross Margin: | $467.9M |
| Return on Equity: | 4.43% |
| Return on Assets: | 2.46% |
Hexcel Corp. Earnings Forecast
Key Hexcel Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for HXL is 24.59%.
-
The Selling, General & Administrative Expenses for HXL have been equal to 9.28% of Gross Profit Margin.
-
The Research & Development expenses have been 3.00% of Revenue.
-
The Interest Expense is 23.62% of Operating Income.
-
The Net Earning history of HXL is 6.94% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 20 years.
Hexcel Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | HXL |
| CUSIP: | 428291 |
| Website: | hexcel.com |
Debt
| Debt-to-Equity Ratio: | 0.48 |
|---|---|
| Current Ratio: | 2.75 |
| Quick Ratio: | 1.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 47.36 |
|---|---|
| Forward P/E Ratio: | 31.84 |
HXL Technical Analysis vs Fundamental Analysis
Buy
56
Hexcel Corp. (HXL)
is a Buy
Is Hexcel Corp. a Buy or a Sell?
-
Hexcel Corp. stock is rated a BuyThe current Hexcel Corp. [HXL] share price is $75.38. The Score for HXL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.